Cyanobacteria, commonly known as blue-green algae, are found almost everywhere in the world—from hot springs to arctic ice to ...
Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common ...
ZME Science on MSN
Chinese Scientists Discover Fern That Forges Rare Earth Crystals and Opens Door to ‘Green Mining’
This fern was already known to be a hyperaccumulator, able to thrive in REE-rich soils in southern China by absorbing the metals. The researchers from the Guangzhou Institute of Geochemistry wanted to ...
The field of infectious disease research is undergoing rapid transformation due to the continuous emergence of novel bacterial threats and the accelerating ...
New solutions involve using AI, studying wastewater for early detection – and mining the Tree of Life for compounds that helped in the ancient past.
Using genomics, evolutionary biologists test several hypotheses on the origin of viruses. New evidence suggests they may have ...
By reactivating a long-lost gene, researchers were able to lower uric acid levels and stop damaging fat accumulation in human ...
ZME Science on MSN
Inside the Human Gene Editing Boom Driven by CRISPR Reshaping Everything From Medicine to Food
CRISPR-based technology is advancing rapidly, driving international competition. Its promise to transform medicine is colliding with political and social realities, even as applications expand.
4don MSN
How scientists are hacking bacteria to treat cancer, self-destruct, then vanish without a trace
Bacteria can serve as couriers for these anti-cancer vaccines. Using genetic engineering, the genetic instructions (or DNA) ...
4don MSN
First-in-human trial of CRISPR gene-editing therapy safely lowers cholesterol and triglycerides
In a 15-patient, Phase 1, first-in-human trial, a one-time CRISPR-Cas9 gene-editing therapy safely reduced LDL cholesterol ...
News-Medical.Net on MSN
One-time CRISPR therapy safely lowers cholesterol and triglycerides in early trial
In a 15-patient, Phase 1 one, first-in-human trial, a one-time, CRISPR-Cas9 gene-editing therapy safely reduced LDL ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results